Glucose intolerance was intensified by the end of the treatment (S1E and S1F Fig), with no changes in basal glycemia (S1G Fig) and plasma leptin and insulin levels (S1H and S1I Fig). The gene discussed is INS; the disease is Glucose intolerance.